mevalonic acid has been researched along with Hutchinson Gilford Progeria Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bikkul, MU; Bridger, JM; Clements, CS; Eskiw, C; Kill, IR; Makarov, E; Ofosu, W; Tree, D | 1 |
1 other study(ies) available for mevalonic acid and Hutchinson Gilford Progeria Syndrome
| Article | Year |
|---|---|
Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways.
Topics: Cell Line; Enzyme Inhibitors; Humans; Lamin Type A; Mevalonic Acid; Progeria | 2019 |